Jump Trading’s Astria Therapeutics ATXS Stock Holding History

Jump Trading’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,929	Closed	-$187K	–	342
2019 Q1	$187K	Buy	+3,929	New	+$133K	0.06%	393

Other funds holding ATXS

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Jump Trading's ATXS Position: Q2 2019 in Review

Jump Trading sold out of Astria Therapeutics (ATXS) in Q2 2019, closing a stake of 3,929 shares — an estimated $187K sold.

Jump Trading first reported a position in ATXS in Q1 2019 and held it in 1 quarter. The position peaked at $187K in Q1 2019. 24 funds tracked by Wall St. Rank hold ATXS as of Q2 2019.

Jump Trading reported no remaining Astria Therapeutics position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 3,929 Astria Therapeutics shares in Q2 2019, an estimated $187K.
Jump Trading first reported a position in Astria Therapeutics in Q1 2019 and held it in 1 quarter.
Jump Trading's Astria Therapeutics position peaked at $187K in Q1 2019.
24 funds tracked by Wall St. Rank held Astria Therapeutics as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.